ArticlePLoS neglected tropical diseases2026
Mycetoma as a major cause of limb amputation in Northeastern Ethiopia: A facility-based retrospective study.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Mycetoma is a chronic, progressively destructive infection that can result in severe disability and limb loss. In Ethiopia, diagnostic capacity and access to effective treatment remain limited, and the burden of mycetoma is poorly characterized. Recent clinical observations from the Afar Region suggest a high frequency of advanced disease and amputation, yet systematic evidence on the burden is lacking. This study aimed to describe the clinical burden of mycetoma, diagnostic and treatment practices, care-seeking patterns, and the extent of limb amputation at Dubti General Hospital in Afar region, northeastern Ethiopia. We conducted a facility-based retrospective review of all patients with a clinical diagnosis of mycetoma managed at Dubti General Hospital between September 2020 and August 2025. Demographic characteristics, clinical presentation, diagnostic investigations, treatment modalities, disability status, and surgical outcomes were summarized descriptively. Factors associated with delayed presentation (>12 months from symptom onset) were assessed using multivariable logistic regression. A total of 143 patients were identified, with a mean age of 30.9 years (SD ± 11.7); 79% were male, 85.3% resided in rural areas, and 46% were pastoralists. All cases involved the lower limb and presented with localized swelling. Pain (90.9%), warmth (54.5%), sinus formation (42.7%), and discharge (40.6%) were common. Diagnosis relied primarily on clinical assessment alone (58.7%), with limited use of imaging and biopsy. The mean duration of illness before first presentation was 33.8 months (SD ± 29), and 89.5% of patients presented after more than 12 months of symptoms. Compared with farmers, merchants had lower odds of delayed presentation (AOR = 0.89, 95% CI: 0.27-0.59). Nineteen patients (13.3%) underwent limb amputation, accounting for 23.5% of all orthopaedic amputations performed at the hospital during the study period. Disability at presentation was frequent, with 14.0% of patients experiencing severe motor impairment. Mycetoma in Afar predominantly affects young rural men and presents almost exclusively with advanced lower-limb disease. Profound diagnostic limitations, delayed care-seeking, and restricted surgical options contribute to poor outcomes. Integrating mycetoma into national neglected tropical disease strategies, strengthening early detection and diagnostic services, ensuring consistent access to essential medications, and expanding limb-sparing surgical capacity are critical to reducing preventable disability and aligning Ethiopia's response with global NTD control targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.